Clinical experience with artificial liver support systems.
Fulminant hepatic failure is a devastating disease that, despite recent therapeutic advances, continues to be associated with high morbidity and mortality. Orthotopic liver transplantation has emerged as the sole modality of treatment that significantly improves survival. However, the critical shortage of donors precludes timely transplantation for all patients. Consequently, almost half of all patients with fulminant hepatic failure die before a graft becomes available. This has generated interest in developing a system that would support patients until either native liver regeneration occurs or an optimal donor liver can be found. Investigators have used biological, artificial and bioartificial techniques in an attempt to improve survival in liver failure. This article reviews the history, the current state of the art and future directions of artificial liver support.
Ting
P P
PP
Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Demetriou
A A
AA
D000818:Animals; D049673:History, 20th Century; D006801:Humans; D017093:Liver Failure / Q000628:therapy*; D019164:Liver, Artificial / Q000266:history